Agrylin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Anagrelide Hydrochloride.
Product ID | 54092-063_2e8a557f-0338-47ff-9ba8-ff4bbf193d1b |
NDC | 54092-063 |
Product Type | Human Prescription Drug |
Proprietary Name | Agrylin |
Generic Name | Anagrelide Hydrochloride |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1997-03-14 |
Marketing Category | NDA / NDA |
Application Number | NDA020333 |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Substance Name | ANAGRELIDE HYDROCHLORIDE |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 1997-03-14 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020333 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1997-03-14 |
Ingredient | Strength |
---|---|
ANAGRELIDE HYDROCHLORIDE | .5 mg/1 |
SPL SET ID: | cb960074-99c1-4a73-941f-f0644a7ec219 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
54092-063 | Agrylin | anagrelide hydrochloride |
0172-5240 | Anagrelide Hydrochloride | Anagrelide Hydrochloride |
0172-5241 | Anagrelide Hydrochloride | Anagrelide Hydrochloride |
68151-2959 | Anagrelide Hydrochloride | Anagrelide Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AGRYLIN 78609806 3119751 Live/Registered |
Shire LLC 2005-04-15 |
AGRYLIN 75195604 2160991 Dead/Cancelled |
SHIRE LLC 1996-11-12 |